Coverage
Filings
| Filing | Date |
|---|---|
| SHARE ACQUISITIONS 16/08/2010 | 16 Aug 2010 |
| SHARE ACQUISITIONS 13/08/2010 | 13 Aug 2010 |
| 435,019 Orion A-shares converted into B-shares | 13 Aug 2010 |
| SHARE ACQUISITIONS 12/08/2010 | 12 Aug 2010 |
| SHARE ACQUISITIONS 11/08/2010 | 11 Aug 2010 |
| CORRECTION: SHARE ACQUISITIONS 11/08/2010 | 11 Aug 2010 |
| Orion Group Interim Report January-June 2010 | 10 Aug 2010 |
| Orion Corporation's publication schedules for financial reporting in 2011 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 10 Aug 2010 |
| Orion invites analysts and media to Q2 news conference on Tuesday 10 August 2010 | 19 Jul 2010 |
| Orion and Sun settle patent dispute | 22 Jun 2010 |
| 20,138 Orion A-shares converted into B-shares | 17 Jun 2010 |
| Composition of R&D Committee as of 15 June 2010 | 15 Jun 2010 |